The DOI matches its Crossref record; 164 of the 173 references it cites were found in a registry or an index.
Chemokines in cancer
Abstract
Chemokines participate, by regulating cell trafficking and controlling angiogenesis, in the host response during infection and inflammation. Most of these mechanisms are also operating in cancer. The stimulation of angiogenesis and tumor growth--directly or indirectly through the recruitment of tumor-associated macrophages--are typical situations where chemokines promote tumor development. On the other hand, chemokines could be used to the benefit of cancer patients as they act in the recruitment of dendritic cells (DC) or/and effector cells or for their angiostatic properties. However, chemokine-mediated recruitment of immature DC within tumors, due to factors produced by the tumor milieu, could lead to the induction of immune tolerance and, therefore, novel strategies to eradicate tumors based on chemokines should attempt to avoid this risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other CXCR2 ligands have been identified as having autocrine roles in the growth of pancreatic, head and neck, and non-small-cell lung carcinoma44,45”
From Inflammation and cancer (2002) · cites this paper as [44]
In the citing paper
“It is well established that CXC chemokines with the three amino acids (Glu-Leu-Arg/ELR) immediately amino-terminal to the CXC motif (ELR+) are pro-angiogenic and stimulate endothelial cell chemotaxis”
From Inflammation and cancer (2002) · cites this paper as [44]
In the citing paper
“whereas ELR− CXC chemokines (for example, PF-4/CXCL4, MIG/CXCL9 and IP-10/CXCL10) possess angiostatic activities44,49.”
From Inflammation and cancer (2002) · cites this paper as [44]
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,496
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O’Garra, A., Bigler, M., Rouleau, M., Antonenko, S. V., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,350
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner‐Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,348
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909.909_909_928 · Cited by 2,126
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,089
Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation
Rissoan, M., Soumelis, V., Kadowaki, N., Grouard, G., Brière, F., Malefyt, R. D. W., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.283.5405.1183 · Cited by 1,835
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1213 · Cited by 1,538
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,535
Shimizu, J., Yamazaki, S., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5211 · Cited by 1,491
Dieu‐Nosjean, M., Vanbervliet, B., Vicari, A. P., Bridon, J., Oldham, E., Aït‐Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,424
Self-citationDhodapkar, M. V., Steinman, R. M., Krasovsky, J., Münz, C., & Bhardwaj, N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.233 · Cited by 1,359
Sauter, B., Albert, M. L., Francisco, L. M., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,357
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,245
Regulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Akbari, O., DeKruyff, R. H., & Umetsu, D. T. (2001) · Nature Immunology · doi:10.1038/90667 · Cited by 1,196
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. P. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,088
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,054
Gunn, M. D., Kyuwa, S., Tam‐Amersdorfer, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019
T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal
Kaliński, P., Hilkens, C. M. U., Wierenga, E. A., & Kapsenberg, M. L. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01547-9 · Cited by 933
Huang, F., Platt, N., Wykes, M., Major, J. R., Powell, T. J., Jenkins, C. D., & MacPherson, G. G. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.435 · Cited by 902
Legler, D. F., Loetscher, M., Roos, R. S., Clark‐Lewis, I., Baggiolini, M., & Moser, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.655 · Cited by 838
Bais, C., Santomasso, B., Coso, O. A., Arvanitakis, L., Geras‐Raaka, E., Gutkind, J. S., Asch, A. S., Cesarman, E., Gerhengorn, M. C., & Mesri, E. A. (1998) · Nature · doi:10.1038/34193 · Cited by 829
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
Gunn, M. D., Ngo, V. N., Ansel, K. M., Ekland, E. H., Cyster, J. G., & Williams, L. T. (1998) · Nature · doi:10.1038/35876 · Cited by 825
Mig and IP-10: CXC chemokines that target lymphocytes
Farber, J. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.246 · Cited by 788
Chemokines as regulators of T cell differentiation
Luther, S. A., & Cyster, J. G. (2001) · Nature Immunology · doi:10.1038/84205 · Cited by 736
(2000) · PubMed · Cited by 706
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.1.155 · Cited by 704
Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 698
Iwasaki, A., & Kelsall, B. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.229 · Cited by 636
Dendritic cell lineage, plasticity and cross-regulation
Liu, Y.-J., Kanzler, H., Soumelis, V., & Gilliet, M. F. (2001) · Nature Immunology · doi:10.1038/89726 · Cited by 608
Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., & Banchereau, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1417 · Cited by 544
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 509
Differentiation of T Regulatory Cells by Immature Dendritic Cells
Roncarolo, M., Levings, M. K., & Traversari, C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.f5 · Cited by 489
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
Sgadari, C., Angiolillo, A., & Tosato, G. (1996) · Blood · doi:10.1182/blood.v87.9.3877.bloodjournal8793877 · Cited by 476
Stumbles, P. A., Thomas, J. A., Pimm, C. L., Lee, P. T., Venaille, T. J., Proksch, S., & Holt, P. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2019 · Cited by 464
Brocker, T., Riedinger, M., & Karjalainen, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.541 · Cited by 451
Alpha and β chemokines induce NK cell migration and enhance NK-mediated cytolysis
Taub, D. D., Sayers, T. J., Carter, C. R., & Ortaldo, J. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3877 · Cited by 448
Activation of Dual T Cell Signaling Pathways by the Chemokine RANTES
Bacon, K. B., Premack, B. A., Gardner, P. I., & Schall, T. J. (1995) · Science · doi:10.1126/science.7569902 · Cited by 440
Tumor-induced immune dysfunction: the macrophage connection
Elgert, K. D., Alleva, D. G., & Mullins, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.275 · Cited by 426
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
Schuler, G., & Steinman, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1183 · Cited by 419
Yang, T., Chen, S., Leach, M. W., Manfra, D. J., Homey, B., Wiekowski, M., Sullivan, L., Jenh, C., Narula, S. K., Chensue, S. W., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.445 · Cited by 416
Luca, M., Huang, S., Gershenwald, J. E., Singh, R. K., Reich, R., & Bar‐Eli, M. (1997) · Europe PMC (PubMed Central) · Cited by 414
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.
Luster, A. D., & Leder, P. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.1057 · Cited by 413
Liao, F., Rabin, R. L., Smith, C. S., Sharma, G., Nutman, T. B., & Farber, J. M. (1999) · PubMed · Cited by 396
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
Enk, A., Jonuleit, H., Saloga, J., & Knop, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3 · Cited by 390
Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9775 · Cited by 377
TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
Geissmann, F., Revy, P., Régnault, A., Lepelletier, Y., Dy, M., Brousse, N., Amigorena, S., Hermine, O., & Durandy, A. (1999) · PubMed · Cited by 373
Damme, J. V., Proost, P., Lenaerts, J., & Opdenakker, G. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.1.59 · Cited by 371
Kaliński, P., Schuitemaker, J. H. N., Hilkens, C. M. U., & Kapsenberg, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2804 · Cited by 370
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
Smith, D. R., Polverini, P. J., Kunkel, S. L., Orringer, M. B., Whyte, R. I., Burdick, M. D., Wilke, C. A., & Strieter, R. M. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1409 · Cited by 368
Strassmann, G., Patil-koota, V., Finkelman, F. D., Fong, M., & Kambayashi, T. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2365 · Cited by 364
Liao, F., Rabin, R. L., Smith, C. S., Sharma, G., Nutman, T. B., & Farber, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.186 · Cited by 362
Inoue, K., Slaton, J. W., Eve, B. Y., Kim, S. J., Perrotte, P., Balbay, M. D., Yano, S., Bar‐Eli, M., Radinsky, R., Pettaway, C. A., et al. (2000) · PubMed · Cited by 361
The host—tumor immune conflict: from immunosuppression to resistance and destruction
Chouaı̈b, S., Asselin‐Paturel, C., Mami‐Chouaib, F., Caignard, A., & Blay, J. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01115-8 · Cited by 353
Regulation of the Macrophage Content of Neoplasms by Chemoattractants
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., & Mantovani, A. (1983) · Science · doi:10.1126/science.6828888 · Cited by 352
Negus, R. P. M., Stamp, G. W. H., Hadley, J., & Balkwill, F. R. (1997) · Europe PMC (PubMed Central) · Cited by 341
Epithelial cancer cell migration: a role for chemokine receptors?
Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., & Balkwill, F. R. (2001) · PubMed · Cited by 335
TGF-β1 Prevents the Noncognate Maturation of Human Dendritic Langerhans Cells
Geissmann, F., Revy, P., Régnault, A., Lepelletier, Y., Dy, M., Brousse, N., Amigorena, S., Hermine, O., & Durandy, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4567 · Cited by 333
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S. V., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Negus, R. P., Stamp, G. W., Relf, M. G., Burke, F., Malik, S. T., Bernasconi, S., Allavena, P., Sozzani, S., Mantovani, A., & Balkwill, F. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117933 · Cited by 315
Chemokines and their role in tumor growth and metastasis
Wang, J. M., Deng, X., Gong, W., & Su, S. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00128-8 · Cited by 310
Mazzucchelli, L., Blaser, A., Каппелер, А., Schaerli, P., Laissue, J. A., Baggiolini, M., & Uguccioni, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7830 · Cited by 299
Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., & Ben‐Baruch, A. (1999) · PubMed · Cited by 297
Ronchetti, A. B., Rovere, P. Q., Iezzi, G., Galati, G., Heltai, S., Protti, M. P., Garancini, M. P., Manfredi, A. A., Rugarli, C., & Bellone, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.130 · Cited by 293
Boon, T., & Old, L. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80049-0 · Cited by 286
Kadowaki, N., Antonenko, S. V., & Liu, Y.-J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2291 · Cited by 278
Dieu‐Nosjean, M., Vicari, A. P., Lebecque, S., & Caux, C. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.2.252 · Cited by 266
Self-citationProcessing of engulfed apoptotic bodies yields T cell epitopes
Bellone, M., Iezzi, G., Rovere, P. Q., Galati, G., Ronchetti, A. B., Protti, M. P., Davoust, J. M., Rugarli, C., & Manfredi, A. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5391 · Cited by 261
Mig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya‐Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 247
Niwa, Y., Akamatsu, H., Niwa, H., Sumi, H., Ozaki, Y., & Abe, A. (2001) · PubMed · Cited by 244
The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
Soto, H., Wang, W., Strieter, R. M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Hedrick, J. A., & Zlotnik, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8205 · Cited by 238
Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
Rollins, B. J., & Sunday, M. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3125 · Cited by 217
Yamaguchi, Y., Tsumura, H., Miwa, M., & Inaba, K. (1997) · Stem Cells · doi:10.1002/stem.150144 · Cited by 215
Combined chemokine and cytokine gene transfer enhances antitumor immunity
Dilloo, D., Bacon, K. B., Holden, W. T., Zhong, W., Burdach, S. E. G., Zlotnik, A., & Brenner, M. K. (1996) · Nature Medicine · doi:10.1038/nm1096-1090 · Cited by 207
Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo
Sharma, S. P., Stolina, M., Luo, J., Strieter, R. M., Burdick, M. D., Zhu, L. X., Batra, R. K., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4558 · Cited by 204
Bottazzi, B., Walter, S., Govoni, D., Colotta, F., & Mantovani, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1280 · Cited by 202
Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12
Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya‐Feldstein, J., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.5.1612.405a13_1612_1621 · Cited by 201
Lymphoid Tissue Homing Chemokines Are Expressed in Chronic Inflammation
Hjelmström, P., Fjell, J., Nakagawa, T., Sacca, R. E., Cuff, C. A., & Ruddle, N. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64981-4 · Cited by 195
Chemokines in lymphopoiesis and lymphoid organ development
Ansel, K. M., & Cyster, J. G. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00201-6 · Cited by 184
Huang, M., Sharma, S. P., Mao, J. T., & Dubinett, S. (1996) · Journal of Immunology · doi:10.4049/jimmunol.157.12.5512 · Cited by 184
Fan, L., Reilly, C. R., Luo, Y., Dorf, M. E., & Lo, D. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.3955 · Cited by 183
Nair, S. K., Hull, S., Coleman, D., Gilboa, E., Lyerly, H. K., & Morse, M. A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990702)82:1 · Cited by 174
Chemokines and Dendritic Cell Traffic
Sozzani, S., Allavena, P., Vecchi, A., & Mantovani, A. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1006659211340 · Cited by 171
Fushimi, T., Kojima, A., Moore, M. A. S., & Crystal, R. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7548 · Cited by 170
Bais, C., Santomasso, B., Coso, O. A., Arvanitakis, L., Geras‐Raaka, E., Gutkind, J. S., Asch, A. S., Cesarman, E., Gershengorn, M. C., & Mesri, E. A. (1998) · Nature · Cited by 164
Zeid, N. A., & Muller, H. K. (1993) · Pathology · doi:10.3109/00313029309090853 · Cited by 163
The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
Arenberg, D. A., Polverini, P. J., Kunkel, S. L., Shanafelt, A. B., Hesselgesser, J., Horuk, R., & Strieter, R. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.554 · Cited by 158
RANTES and MIP-1α Activate Stats in T Cells
Wong, M., & Fish, E. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.309 · Cited by 157
Kirk, C. J., Hartigan-O’Connor, D. J., Nickoloff, B. J., Chamberlain, J. S., Giedlin, M. A., Aukerman, L., & Mulé, J. J. (2001) · PubMed · Cited by 155
Burger, M., Burger, J. A., Hoch, R. C., Oades, Z. G., Takamori, H., & Schraufstätter, I. U. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2017 · Cited by 155
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms
Vicari, A. P., Aït‐Yahia, S., Chemin, K., Müeller, A., Zlotnik, A., & Caux, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1992 · Cited by 153
Self-citationMacrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines
Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Strom, S. R. B., Burdick, M. D., Iannettoni, M. D., & Strieter, R. M. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050603 · Cited by 153
Sica, A., Saccani, A., Bottazzi, B., Bernasconi, S., Allavena, P., Gaetano, B., Fei, F., LaRosa, G., Scotton, C. J., Balkwill, F. R., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.733 · Cited by 151
PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCER
Troy, A., DAVIDSON, P., Atkinson, C. H., & Hart, D. N. J. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63093-3 · Cited by 151
Viral G Protein–Coupled Receptor and Kaposi's Sarcoma
Cesarman, E., Mesri, E. A., & Gershengorn, M. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.417 · Cited by 151
Hirao, M., Onai, N., Hiroishi, K., Watkins, S. C., Matsushima, K., Robbins, P. D., Lotze, M. T., & Tahara, H. (2000) · PubMed · Cited by 149
Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells
Norgauer, J., Metzner, B., & Schraufstätter, I. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1132 · Cited by 144
Autocrine Growth Effect of IL-8 and GRO?? on a Human Pancreatic Cancer Cell Line, Capan-1
Takamori, H., Oades, Z. G., Hoch, R. C., Burger, M., & Schraufstätter, I. U. (2000) · Pancreas · doi:10.1097/00006676-200007000-00051 · Cited by 141
Reiter, I., Krammer, B. E., & Schwamberger, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1730 · Cited by 139
Papillary Carcinoma of the Thyroid
Scarpino, S., Stoppacciaro, A., Ballerini, F., Marchesi, M., Prat, M., Stella, M. C., Sozzani, S., Allavena, P., Mantovani, A., & Ruco, L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64951-6 · Cited by 135
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer
Valković, T., Lučin, K., Krstulja, M., Dobi-Babić, R., & Jonjić, N. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80057-5 · Cited by 135
Mulé, J. J., Custer, M. C., Averbook, B. J., Yang, J. C.-H., Weber, J. S., Goeddel, D. V., Rosenberg, S. A., & Schall, T. J. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.13-1545 · Cited by 135
Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste, G. H., Kirsh, R. L., Fogler, W. E., & Fidler, I. J. (1979) · PubMed · Cited by 134
Wright, K., Wilson, P. J., Morland, S. J., Campbell, I., Walsh, M. D., Hurst, T., Ward, B. G., Cummings, M. C., & Chenevix‐Trench, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5 · Cited by 134
Yamashiro, S., Takeya, M., Nishi, T., Kuratsu, J. I., Yoshimura, T., Ushio, Y., & Takahashi, K. (1994) · PubMed Central · Cited by 132
Designer dendritic cells for tolerance induction: guided not misguided missiles
Hackstein, H., Morelli, A. E., & Thomson, A. W. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01959-7 · Cited by 130
Purification of melanoma growth stimulatory activity
Richmond, A., & Thomas, H. G. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041290316 · Cited by 128
Yoong, K. F., Afford, S. C., Jones, R. L., AUJLA, P., Qin, S., Price, K., Hübscher, S. G., & Adams, D. (1999) · Hepatology · doi:10.1002/hep.510300147 · Cited by 127
Cass, I. A., Li, A. J., Runowicz, C. D., Fields, A. L., Goldberg, G. L., Leuchter, R. S., Lagasse, L. D., & Karlan, B. Y. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6027 · Cited by 127
Braun, S. E., Chen, K., Foster, R. G., Kim, C. H., Hromas, R., Kaplan, M. H., Broxmeyer, H. E., & Cornetta, K. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4025 · Cited by 126
Fioretti, F., FRADELIZI, D., Stoppacciaro, A., Ramponi, S., Ruco, L., Minty, A. J., Sozzani, S., Garlanda, C., Vecchi, A., & Mantovani, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.342 · Cited by 121
The dendritic cell and human cancer vaccines
Dallal, R. M., & Lotze, M. T. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00146-1 · Cited by 120
Pertl, U., Luster, A. D., Varki, N. M., Homann, D., Gaedicke, G., Reisfeld, R. A., & Lode, H. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6944 · Cited by 107
Kim, C. H., Pelus, L. M., Appelbaum, E. R., Johanson, K., Anzai, N., & Broxmeyer, H. E. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1483 · Cited by 106
Emtage, P. C. R., Wan, Y., Hitt, M., Graham, F. L., Muller, W. J., Zlotnik, A., & Gauldie, J. (1999) · Human Gene Therapy · doi:10.1089/10430349950018463 · Cited by 105
Effects of MGSA/GRO alpha on melanocyte transformation.
Balentien, E., Mufson, B. E., Shattuck, R. L., Derynck, R., & Richmond, A. J. (1991) · PubMed · Cited by 102
Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma
Richards, B. L., Eisma, R. J., Spiro, J. D., Lindquist, R. L., & Kreutzer, D. L. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00165-7 · Cited by 100
gi, R. K., & Volm, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990621)84:3 · Cited by 99
Design and evaluation of antigen-specific vaccination strategies against cancer
Offringa, R., van der Burg, S. H., OSSENDORP, F. A., Toes, R. E. M., & Melief, C. J. M. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00145-x · Cited by 97
Expression of theJE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells
Huang, S., Singh, R. K., Xie, K., Gutman, M., Berry, K. K., Bucana, C. D., Fidler, I. J., & Bar‐Eli, M. (1994) · Cancer Immunology Immunotherapy · doi:10.1007/bf01525986 · Cited by 95
Amann, Perabo, Wirger, Hugenschmidt, H., & Schultze‐Seemann (1998) · British Journal of Urology · doi:10.1046/j.1464-410x.1998.00675.x · Cited by 90
Burger, H., Nooter, K., Boersma, A. W. M., van Wingerden, K. E., Looijenga, L. H. J., Jochemsen, A. G., & Stoter, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4 · Cited by 89
Bottazzi, B., Colotta, F., Sica, A., Nobili, N., & Mantovani, A. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450436 · Cited by 88
T Cells and Dendritic Cells Get Intimate
Bottomly, K. (1999) · Science · doi:10.1126/science.283.5405.1124 · Cited by 87
Giovarelli, M., Cappello, P., Forni, G., Salcedo, T. W., Moore, P. A., LeFleur, D. W., Nardelli, B., Carlo, E. D., Lollini, P., Ruben, S. M., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3200 · Cited by 86
Bordoni, R., Fine, R. M., Murray, D., & Richmond, A. J. (1990) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240440403 · Cited by 86
Beck, A., P�zolt, D., Grabenbauer, G. G., Nicholls, J. M., Herbst, H., Young, L. S., & Niedobitek, G. (2001) · The Journal of Pathology · doi:10.1002/path.867 · Cited by 82
Tang, K. F., Tan, S. Y., Chan, S. H., Chong, S. M., Loh, K. S., Tan, L. K. S., & Hu, H. (2001) · Human Pathology · doi:10.1053/hupa.2001.20886 · Cited by 79
Ghia, P., Transidico, P., Veiga, J. P., Schaniel, C., Sallusto, F., Matsushima, K., Sallan, S. E., Rolink, A. G., Mantovani, A., Nadler, L. M., et al. (2001) · Blood · doi:10.1182/blood.v98.3.533 · Cited by 75
Cairns, C. M., Gordon, J., Li, F., Baca‐Estrada, M. E., Moyana, T. N., & Xiang, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.57 · Cited by 74
Maghazachi, A. A., & Al-Aoukaty, A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.913 · Cited by 74
Peh, S. C., Kim, L., & Poppema, S. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200107000-00011 · Cited by 72
Mellado, M., de Ana, A. M., Moreno, M. C., Martínez‐A, C., & Rodrı́guez-Frade, J. M. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00199-3 · Cited by 71
IN VIVO DESCRIPTION OF DENDRITIC CELLS IN HUMAN RENAL CELL CARCINOMA
Schwaab, T., Schned, A. R., Heaney, J. A., Cole, B. F., ATZPODIEN, J., Wittke, F., & Ernstoff, M. S. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68628-4 · Cited by 69
Riethdorf, L., Riethdorf, S., Gützlaff, K., Prall, F., & Löning, T. (1996) · Europe PMC (PubMed Central) · Cited by 67
Nakashima, E., Mukaida, N., Kubota, Y., Kuno, K., Yasumoto, K., Ichimura, F., Nakanishi, I., Miyasaka, M., & Matsushima, K. (1995) · Pharmaceutical Research · doi:10.1023/a:1016276613684 · Cited by 64
Chemokine Receptor Desensitization in Tumor-Bearing Mice
Kurt, R. A., Baher, A., Wisner, K. P., Tackitt, S., & Urba, W. J. (2001) · Cellular Immunology · doi:10.1006/cimm.2000.1754 · Cited by 55
Dobrzanski, M. J., Reome, J. B., & Dutton, R. W. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4945 · Cited by 52
Kinoshita, M., Johnson, D. L., Shatney, C. H., Lee, Y. L., & Mochizuki, H. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999 · Cited by 51
Prognostic Significance of Accessory Cells and Lymphocytes in Nasopharyngeal Carcinoma
Giannini, A., Bianchi, S., Messerini, L., Gallo, O., Gallina, E., Libonati, G. A., Olmi, P., & Zampi, G. (1991) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80013-0 · Cited by 51
Nokihara, H., Yanagawa, H., Nishioka, Y., Yano, S., Mukaida, N., Matsushima, K., & Sone, S. (2000) · PubMed · Cited by 49
Hildenbrand, R., Schröder, W., Brude, E., Schepler, A., König, R., Stutte, H. J., & Arnemann, J. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199912)189:4 · Cited by 46
Gap junctions in normal and neoplastic mammary gland
Locke, D. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199812)186:4 · Cited by 42
Marić, M., & Liu, Y. (1999) · PubMed · Cited by 37
Wakabayashi, H., Cavanaugh, P. G., & Nicolson, G. L. (1995) · PubMed · Cited by 28
Ramakrishna, V., Negri, D. R. M., Brusić, V., Fontanelli, R., Canevari, S., Bolis, G., Castelli, C., & Parmiani, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1 · Cited by 26
Hoshino, Y., Hatake, K., Kasahara, T., Takahashi, Y., Ikeda, M., Tomizuka, H., Ohtsuki, T., Uwai, M., Mukaida, N., & Matsushima, K. (1995) · PubMed · Cited by 25
Expression of the Chemokines IP-10 and Mig in IL-10 Transduced Tumors
Sun, H., Kundu, N., Dorsey, R. M., Jackson, M. J., & Fulton, A. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00008 · Cited by 24
Olbina, G., Cieslak, D., Ruždijić, S., Esler, C. P., An, Z., Wang, X., Hoffman, R. M., Seifert, W., & Pietrzkowski, Z. J. (1996) · PubMed · Cited by 21
Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma.
Jonjić, N., Valković, T., Lučin, K., Iternicka, Z., Krstulja, M., Mustać, E., Dobi-Babić, R., Sasso, F., & Melato, M. (1998) · PubMed · Cited by 21
Cytokine and Chemokine: A Stimulating Couple
Paillard, F. (1999) · Human Gene Therapy · doi:10.1089/10430349950018454 · Cited by 19
Saji, F., Ohashi, K., Tokugawa, Y., Kamiura, S., Azuma, C., & Tanizawa, O. (1990) · Cancer · doi:10.1002/1097-0142(19901101)66:9 · Cited by 18
Research works printed but not linked: 1
- Rollins, 1997, Chemokines. Blood, 90, 909, 10.1182/blood.V90.3.909 · DOI
Cited by
Sorted by citations
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,235
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,483
Murdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 943
Metadata
- Authors
- Vicari, A. P., & Caux, C.
- Corresponding author
- Vicari, Alain P
- ORCID
- Caux, Christophe
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 13
- Issue
- 2
- Pages
- 143-154
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W2092021793
- Cited by
- 351
- References
- 173
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 9 · 2020: 14 · 2019: 11 · 2018: 9 · 2017: 13 · 2016: 12 · 2015: 16 · 2014: 20 · 2013: 18 · 2012: 21
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- chemokines, cancer, angiogenesis, tumor growth, tumor-associated macrophages, dendritic cell recruitment, immune tolerance, tumor microenvironment, cell trafficking
- MeSH terms
- Animals, Dendritic Cells, Humans, Killer Cells, Natural, Leukocytes, Models, Biological, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, T-Lymphocytes, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review